| Literature DB >> 33911411 |
Verdiana Di Pietro1, Gianfranco Marcello Colicchia2, Valerio Cervelli2.
Abstract
INTRODUCTION: Following massive weight loss (MWL), medial contouring of the thigh is frequently requested to improve the appearance and function. Thigh lifting can be associated with significant complications if the medial thigh excess is removed en bloc. In this article, we describe the Liposuction-Assisted Medial Thigh Lift (LAMeT) and evaluate the outcomes and complications in a retrospective cohort study.Entities:
Keywords: Body contouring; liposuction; massive weight loss; thigh lift
Year: 2020 PMID: 33911411 PMCID: PMC8061643 DOI: 10.4103/JCAS.JCAS_130_18
Source DB: PubMed Journal: J Cutan Aesthet Surg ISSN: 0974-2077
Figure 1LAMeT preoperative markings
Figure 2LAMeT surgical technique step by step. (A) Liposuction area injection. (B) Liposuction of the ellipse of resection: all the subcutaneous fat has been removed. (C) Skin incision. (D) Subdermal resection of the excess skin to preserve the underneath connective network
Figure 3Detail of the spiral running suture. The suture is blocked with two passages of the thread at the same level and if possible through the thread itself
Demographic data: no significant differences are observed between the two groups
| Overall | Excision-Only | Liposuction-Assisted | ||
|---|---|---|---|---|
| No. of patients | 54 | 28 | 26 | |
| Age at surgery, year | 44,16 (min 25, max 61) | 44,44 (min 25, max 61) | 43,63 (min 36, max 52) | >0.05 |
| Mean weight loss, kg | 61,25 (min 22, max 91) | 58,6 (min 22, max 91) | 66,5 (min 41, max 90) | >0.05 |
| BMI at surgery, kg/m2 | 28 (min 22, max 34,16) | 28 (min 22, max 34,16) | 27,94 (min 22,8, max 33,29) | >0.05 |
| Maximum BMI, kg/m2 | 50,73 (min 41,77, max 63,29) | 49,45 (41,77 max 63,29) | 53,3 (min 47, max 60,95) | >0.05 |
| Change in BMI, kg/m2 | 23,88 (min 14,77, max 36,45) | 23,51 (min 14,77, max 36,45) | 24,61 (min 16,35, max 32,27) | >0.05 |
| No. of comorbidities | 14 | 11 | 3 |
BMI = body mass index.
*Statistically significant difference, P < 0.05
Surgical Data: there are no statistically significant differences between the two groups by duration of the intervention; the hospital, time to drain removal and the mean amount of tissue removed were lower in the LAMeT group
| Overall | Excision-Only | Liposuction-Assisted | ||
|---|---|---|---|---|
| No. of patients | 54 | 28 | 26 | |
| Duration, min | 238,33 (min 60, max 375) | 242,19 (min 60, max 360) | 230 (min 190, max 375) | >0.05 |
| Lipoaspirate, ml | 1058,33 (min 0, max 2200) | 0 | 1587,5 (min 800, max 2200) | >0.05 |
| Resection weight, g | 605, 71 (min 100, max 2100) | 715,75 (min 180, max 1950) | 385,62 (min 100, mac 2100) | >0.05 |
| Time to drain removal, days | 1,54 (min 0, max 5) | 2,18 (min 0, max 5) | 0,25 (min 0, max 2) | <0.05 |
| Days Hospital stay, days | 4 (min 2, max 7) | 5 (min 3, max 7) | 2 | >0.05 |
*Statistically significant difference, P < 0.05
Complications: the incidence of complications was significantly lower rate in the LAMET group. No major complications were observed in either group. The incidence of seroma was significantly lower in the LAMET group while no statistically significant findings were observed for hematoma, infection or dehiscence
| Overall | Excision-Only | Liposuction-Assisted | ||
|---|---|---|---|---|
| No. of patients | 54 | 28 | 26 | |
| Seroma | 8 | 8 | 0 | <0.05 |
| Hematoma | 2 | 2 | 0 | >0.05 |
| Wound dehiscence | 9 | 9 | 0 | >0.05 |
| Wound infection | 1 | 0 | 1 | >0.05 |
| Surgical revision | 1 | 1 | 0 | >0.05 |
| Vulva deformation | 0 | 0 | 0 | >0.05 |
| Scar migration | 9 | 8 | 1 | <0.05 |
| Total patients with complications | 13 | 10 | 3 | >0.05 |
*Statistically significant difference, P < 0.05
Figure 4(A) Anterior view of this 36-year-old woman who underwent LAMeT after gastric bypass and weight loss of 50 kg. (B) Six months postoperatively. Note the improvement even in the medial knee region
Figure 7(A) Anterior view of this 41-year-old woman who underwent LAMeT after gastric bypass and weight loss of 60 kg. (B) Twelve months postoperatively. LAMeT guarantee stable results over time with minimal ptosis recurrence